The inferred TF activity was decreased upon IBET‐762 treatment in a broad range of TFs, including all nine TFs with higher inferred activity in trisomy 12 CLL (Fig 4F). The gene discussed is TF; the disease is B-cell chronic lymphocytic leukemia.